GlassScriptPhysician profile
Hai H Pham
NPI 1548223712
$987.23
in general payments reported to CMS, 2019-2025
13 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $24.52 · 2021: $201 · 2022: $122 · 2023: $131 · 2024: $20.64 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $163.32 | 2019 | |
| Novo Nordisk INC | $151.83 | 2021 | |
| Sumitomo Pharma America, INC. | $135.20 | 2025 | Gemtesa |
| Amgen INC. | $122.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $111.86 | 2024-2025 | Breztri, Airsupra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.75 | 2023 | Lifevest |
| Merck Sharp & Dohme LLC | $86.23 | 2021-2023 | Belsomra, Verquvo, Steglatro |
| Astellas Pharma US INC | $35.74 | 2019 | |
| Glaxosmithkline, LLC. | $24.52 | 2020 | |
| Dynavax Technologies Corporation | $19.37 | 2019 | |
| Exact Sciences Corporation | $18.20 | 2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $13.12 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hai Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.